KindlyMD, Inc. (NASDAQ:NAKA) Receives Consensus Recommendation of “Hold” from Analysts

KindlyMD, Inc. (NASDAQ:NAKA) has been given a consensus rating of “Hold” by the five brokerages that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $0.75.

Several equities research analysts recently commented on NAKA shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of KindlyMD in a research report on Friday, March 27th. Maxim Group decreased their price objective on shares of KindlyMD from $1.50 to $0.75 and set a “buy” rating on the stock in a research report on Monday, April 6th. TD Cowen started coverage on shares of KindlyMD in a research report on Friday, April 10th. They issued a “buy” rating and a $1.00 price objective on the stock. Finally, B. Riley Financial decreased their price objective on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research report on Monday, February 23rd.

KindlyMD Stock Performance

Shares of NASDAQ NAKA opened at $0.18 on Tuesday. The firm has a market capitalization of $124.82 million, a P/E ratio of -0.21 and a beta of 17.12. KindlyMD has a one year low of $0.17 and a one year high of $34.77. The company’s fifty day moving average is $0.23 and its two-hundred day moving average is $0.39.

Hedge Funds Weigh In On KindlyMD

Hedge funds have recently bought and sold shares of the stock. Alyeska Investment Group L.P. purchased a new stake in shares of KindlyMD in the fourth quarter valued at $8,993,000. ParaFi Capital LP purchased a new stake in shares of KindlyMD in the third quarter valued at $443,055,000. Hunting Hill Global Capital LLC purchased a new stake in shares of KindlyMD in the fourth quarter valued at $4,672,000. RK Capital Management LLC FL purchased a new position in KindlyMD in the 3rd quarter valued at about $239,052,000. Finally, Yorkville Advisors Global LP purchased a new position in KindlyMD in the 3rd quarter valued at about $231,942,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.